Sonora Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Sonora Investment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$16K	Hold	96	–	–	﹤0.01%	679
2021 Q2	$16K	Buy	96 +21	+28%	+$3.23K	﹤0.01%	618
2021 Q1	$11K	Hold	75	–	–	﹤0.01%	1204
2020 Q4	$11K	Sell	75 -60	-44%	-$8.57K	﹤0.01%	1166
2020 Q3	$18K	Hold	135	–	–	﹤0.01%	947
2020 Q2	$18K	Hold	135	–	–	﹤0.01%	835
2020 Q1	$15K	Hold	135	–	–	﹤0.01%	878
2019 Q4	$16K	Sell	135 -24	-15%	-$2.68K	﹤0.01%	968
2019 Q3	$16K	Buy	159 +135	+563%	+$14.1K	﹤0.01%	960
2019 Q2	$3K	Buy	+24	New	+$2.55K	﹤0.01%	1516

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sonora Investment Management's IBB Position: Q3 2021 in Review

Sonora Investment Management held its iShares Biotechnology ETF (IBB) position steady in Q3 2021 at 96 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #679.

Sonora Investment Management first reported a position in IBB in Q2 2019 and has held it in 10 quarters since. The position peaked at $18K in Q3 2020. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

Sonora Investment Management held 96 shares of iShares Biotechnology ETF worth $16K as of Q3 2021.
Sonora Investment Management left its iShares Biotechnology ETF share count unchanged in Q3 2021.
iShares Biotechnology ETF made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #679 holding.
Sonora Investment Management first reported a position in iShares Biotechnology ETF in Q2 2019 and has held it in 10 quarters since.
Sonora Investment Management's iShares Biotechnology ETF position peaked at $18K in Q3 2020.
855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.